February 23, 2023 Quantitative performance of digital ELISA for the highly sensitive quantification of viral proteins and influenza virus
February 11, 2023 Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson’s disease
February 9, 2023 Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia
February 6, 2023 Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
February 2, 2023 Rapid Activation of Neuroinflammation in Stroke: Plasma and Extracellular Vesicles Obtained on a Mobile Stroke Unit
January 31, 2023 Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood
January 25, 2023 345 Treatment with amlitelimab—a novel non-depleting, non-cytotoxic anti-OX40Ligand monoclonal antibody—reduces IL-22 serum levels in a phase 2a randomized, placebo-controlled trial in patients with moderate-to-severe atopic dermatitis